Low-dose computed tomography screening for lung cancer: How strong is the evidence?

JAMA Internal Medicine

Volumn 174, Issue 12, 2014, Pages 2019-2022

  Woolf, Steven H ^a   Harris, Russell P ^b   Campos Outcalt, Doug ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Southwest Catholic Health Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CERTIFICATION; COMMUNITY PROGRAM; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; FALSE POSITIVE RESULT; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MEDICAL EDUCATION; MEDICARE; RADIATION DOSE; RADIATION EXPOSURE; SMOKING; AGED; EARLY DIAGNOSIS; ECONOMICS; EVIDENCE BASED MEDICINE; FEMALE; HEALTH INSURANCE; INSURANCE; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; PROCEDURES; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; LUNG NEOPLASMS; MALE; MASS SCREENING; MEDICARE; MIDDLE AGED; RADIATION DOSAGE; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84919467978     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.5626     Document Type: Article

References (32)

1. Brownlee S. Overtreated: Why Too Much Medicine is Making us Sicker and Poorer. New York, NY: Bloomsbury USA; 2007.
2. Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330-338.
3. Centers for Medicare & Medicaid Services. Meetingminutes of the Centers for Medicare & Medicaid Services Medicare Evidence Development and Coverage Advisory Committee, April 30, 2014: lung cancer screening with low-dose computed tomography. http://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/downloads/id68d.pdf. Accessed August 30, 2014.
4. Oken MM, Hocking WG, Kvale PA, et al; PLCO Project Team. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011;306(17):1865-1873.
5. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5): 395-409.
6. Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer. 2013;119(22):3976-3983.
7. de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160:311-320.
8. Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144(1):33-38.
9. Wender R, Fontham ET, Barrera E Jr, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):107-117.
10. American College of Radiology. Guidance for ACR members on lung cancer screening with CT. http://www.acr.org/News-Publications/News/News-Articles/2013/Quality-Care/20130624-Guidance-for-ACR-Members-on-Lung-Cancer-Screening-with-CT. Accessed August 30, 2014.
11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. http://www.nccn.org/professionals/physician-gls/pdf/lung-screening.pdf. Accessed August 30, 2014.
12. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5)(suppl): e78S-e92S.
13. InfanteM, Cavuto S, Lutman FR, et al; DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009;180(5):445-453.
14. Lopes Pegna A, Picozzi G, Mascalchi M, et al; ITALUNG Study Research Group. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer. 2009;64(1):34-40.
15. van den Bergh KA, Essink-Bot ML, Borsboom GJ, Scholten ET, van Klaveren RJ, de Koning HJ. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J. 2011;38(1):154-161.
16. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease: the randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012;67(4): 296-301.
17. Humphrey LL, Deffebach M, Pappas M, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med. 2013;159(6):411-420.
18. Harris RP, Sheridan SL, Lewis CL, et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med. 2014;174(2):281-285.
19. Chin J. Screening for lung cancer with low-dose computed tomography in adult smokers: Presentation, Medicare Evidence Development and Coverage Advisory Committee, April 30, 2014. http://www.cms.gov/medicare-coverage-database/details/medcac-meeting-details.aspx?MEDCACId=68&bc=AAAIAAAAAAAAAA%3d%3d&. Accessed August 30, 2014.
20. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst. 2010;102(23):1771-1779.
21. Church TR, Black WC, Aberle DR, et al; National Lung Screening Trial Research Team. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013;368(21):1980-1991.
22. Aggestrup LM, Hestbech MS, Siersma V, Pedersen JH, Brodersen J. Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial. BMJ Open. 2012;2(2):e000663.
23. Patz EF Jr, Pinsky P, Gatsonis C, et al; NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014; 174(2):269-274.
24. DrazerMW, Prasad SM, Huo D, et al. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making. Cancer. 2014;120(10):1491-1498.
25. Pinsky PF, Gierada DS, HockingW, Patz EF Jr, Kramer BS. National lung screening trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med. doi:10.7326/M14-1484.
26. Kazerooni EA. Lung cancer screening and public health: Presentation, Medicare Evidence Development and Coverage Advisory Committee, April 30, 2014. http://www.cms.gov/medicare-coverage-database/details/medcac-meeting -details.aspx?MEDCACId=68. Accessed August 30, 2014.
27. Kuo E. Lung cancer screening: 2.5 year experience of community program in the heart of valley fever territory: Presentation, Medicare Evidence Development and Coverage Advisory Committee, April 30, 2014. http://www.cms.gov/medicare-coverage-database/details/medcac-meeting-details.aspx?MEDCACId=68&bc=AAAIAAAAAAAAAA%3d%3d&. Accessed August 30, 2014.
28. Daniel GW, Rubens EK, McClellanM. Coverage with evidence development for Medicare beneficiaries: challenges and next steps. JAMA Intern Med. 2013;173(14):1281-1282.
29. Wiener RS. Balancing the benefits and harms of low-dose computed tomography screening for lung cancer: Medicare's options for coverage. Ann Intern Med. 2014. doi:10.7326/M14-1352.
30. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax. 2011;66(4): 308-313.
31. Kinsinger LS, Atkins D, Provenzale D, Anderson C, Petzel R. Implementation of a new screening recommendation in health care: the Veterans Health Administration approach to lung cancer screening ([published online August 12, 2014]). Ann Intern Med. 2014. doi:10.7326/M14-1070.
32. Agaku IT, King BA, Husten CG, et al Centers for Disease Control and Prevention (CDC). Tobacco product use among adults-United States, 2012-2013. MMWR Morb Mortal Wkly Rep. 2014;63 (25):542-547.